Approaching Shared Pathophysiology in Immune-Mediated Diseases through Functional Genomics

Genes (Basel). 2020 Dec 9;11(12):1482. doi: 10.3390/genes11121482.

Abstract

Immune-mediated diseases (IMDs) are complex pathologies that are strongly influenced by environmental and genetic factors. Associations between genetic loci and susceptibility to these diseases have been widely studied, and hundreds of risk variants have emerged during the last two decades, with researchers observing a shared genetic pattern among them. Nevertheless, the pathological mechanism behind these associations remains a challenge that has just started to be understood thanks to functional genomic approaches. Transcriptomics, regulatory elements, chromatin interactome, as well as the experimental characterization of genomic findings, constitute key elements in the emerging understandings of how genetics affects the etiopathogenesis of IMDs. In this review, we will focus on the latest advances in the field of functional genomics, centering our attention on systemic rheumatic IMDs.

Keywords: GWAS; Hi-C; functional genomics; immune-mediated diseases; shared genetics; trancriptomics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Epigenomics / methods
  • Gene Expression Profiling / methods
  • Genetic Loci / genetics
  • Genetic Predisposition to Disease / genetics
  • Genome-Wide Association Study
  • Genomics / methods*
  • Humans
  • Immune System Diseases / genetics*
  • Immune System Diseases / physiopathology*
  • Regulatory Sequences, Nucleic Acid / genetics
  • Transcriptome / genetics